| Oct 30 |
Eli Lilly plans to begin advertising weight-loss drug Zepbound
|
| Oct 30 |
Lilly's Q3 Earnings Miss, Mounjaro, Zepbound Disappoint, Stock Tanks
|
| Oct 30 |
Novo takes big step toward ending Ozempic, Wegovy shortages
|
| Oct 30 |
Eli Lilly drops, sending Novo lower after Q3 miss
|
| Oct 30 |
Eli Lilly stock sinks after Q3 earnings miss Wall Street expectations
|
| Oct 30 |
Eli Lilly Stock Tumbles as Q3 Sales, Profits Fall Well Short of Estimates
|
| Oct 30 |
The Zacks Analyst Blog Apple, Novo Nordisk, RTX and FONAR
|
| Oct 30 |
Lilly shares fall as obesity drug sales miss forecasts
|
| Oct 29 |
Key Novo Nordisk plant where Wegovy, Ozempic made cited by FDA
|
| Oct 29 |
Top Research Reports for Apple, Novo Nordisk & RTX
|
